Table 2 Separate comparison of surgical data and postoperative outcomes

Operative time (min)^a

189.1 ± 45.2

213.3 ± 54.4

416.2 ± 78.8

365.0 ± 81.6

Estimated blood loss (mL)^b

180 (80–600)

220 (120–800)

250 (150–900)

300 (180–1000)

RBC transfusion (%)

3 (3.5%)

10 (11.6%)

14 (13.9%)

22 (21.8%)

Postoperative hospital stay (days)^b

9 (4–34)

13 (7–42)

14 (9–69)

18 (11–52)

Overall morbidity (n, %)

8 (9.3%)

14 (16.3%)

22 (21.8%)

32 (31.7%)

CR-POPF

5

7

12

16

DGE (Grade A/ Grade B, C)

0 (0/0)

3 (2/1)

6 (4/2)

10 (5/5)

PPH (Grade A/ Grade B, C)

0 (0/0)

2 (1/1)

5 (1/4)

6 (3/3)

Bile leak

0

0

2

3

Wound infection

0

2

1

1

Lymphorrhea

1

0

0

2

Pulmonary complications

2

2

2

5

Reoperation (%)

0

0

6 (5.9%)

8 (7.9%)

Clavien-Dindo classification

I-II

4 (4.7%)

5 (5.6%)

10 (9.9%)

16 (15.8%)

III-IV

4 (4.7%)

9 (10.5%)

11 (10.9%)

15 (14.9%)

V (90-day mortality)

0 (0%)

0 (0%)

1 (1.0%)

1 (1.0%)

Adjuvant treatment (%)

61 (70.9%)

57 (66.3%)

67 (66.3%)

65 (64.4%)

Time to adjuvant treatment (days)^a

50 (28–82)

52 (26–88)

59 (26–98)

60 (26–103)